{"symbol": "CUE", "companyName": "Cue Biopharma Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "https://www.cuebiopharma.com", "description": "Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.", "CEO": "Daniel R. Passeri", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}